» Articles » PMID: 30184556

Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy

Abstract

Objective: To examine the association between maternal obesity on left ventricular (LV) size and recovery in women with peripartum cardiomyopathy (PPCM).

Study Design: This was a prospective analysis of 100 women enrolled within 13 weeks of PPCM diagnosis and followed for a year in the Investigation of Pregnancy Associated Cardiomyopathy study. Adiposity was defined by standard body mass index (BMI) definitions for under/normal weight, overweight, and obesity. Demographic, clinical, and biomarker variables were compared across weight categories.

Outcomes: LV end-diastolic diameter (LVEDD) and ejection fraction were measured at entry, 6, and 12 months postpartum. Multivariable regression models examined the relationship between adiposity, LV size, and leptin levels with cardiac recovery at 6 and 12 months postpartum.

Results: Obese and nonobese women had similar LV dysfunction at entry. Obese women had greater LV size and less LV recovery at 6 and 12 months postpartum. BMI was positively associated with leptin and ventricular diameter. Greater BMI at entry remained associated with less ventricular recovery at 6 months ( = 0.02) in adjusted race-stratified models. LVEDD at entry predicted lower ejection fraction at 6 months ( < 0.001) and similarly at 12 months.

Conclusion: Obese women with PPCM had greater cardiac remodeling, higher leptin levels, and diminished cardiac recovery.

Citing Articles

Noninvasive Methods to Track Cardiovascular Hemodynamic Changes in Pregnancy.

Harrington C, Tanguturi V, Goldberg R JACC Adv. 2025; 3(11):101361.

PMID: 39741646 PMC: 11686044. DOI: 10.1016/j.jacadv.2024.101361.


Diagnosis and management of peripartum cardiomyopathy and recurrence risk.

Iannaccone G, Graziani F, Kacar P, Tamborrino P, Lillo R, Montanaro C Int J Cardiol Congenit Heart Dis. 2024; 17:100530.

PMID: 39711771 PMC: 11657248. DOI: 10.1016/j.ijcchd.2024.100530.


CMR and adverse clinical outcomes in peripartum cardiomyopathy.

Koczo A, Acharya D, Ozbay B, Alharethi R, Givertz M, Elkayam U Am Heart J Plus. 2024; 48:100484.

PMID: 39610381 PMC: 11602612. DOI: 10.1016/j.ahjo.2024.100484.


Cardiomyopathy discovered during pregnancy: Insights from speckle tracking echocardiography in a cohort of pregnant patients.

Bahrami P, Soleimani A, Zavar R, Masoumi H, Adelparvar F ARYA Atheroscler. 2024; 20(2):8-16.

PMID: 39170817 PMC: 11335032. DOI: 10.48305/arya.2024.42400.2932.


Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers.

Trimarchi G, Teresi L, Licordari R, Pingitore A, Pizzino F, Grimaldi P Biomedicines. 2024; 12(5).

PMID: 38791012 PMC: 11117605. DOI: 10.3390/biomedicines12051051.